探索马来西亚社区药剂师对体育药房服务的观点:一项定性研究
Ming Chiang Lim1,2, Eng Wee Chua3, Tuan Mazlelaa Tuan Mahmood1
1Centre for Quality Management of Medicines, Faculty of Pharmacy, Universiti Kebangsaan Malaysia, Malaysia.
Journal of public health research
|March 16, 2026
概括
马来西亚社区药剂师认为需要体育药房服务,以保护运动员免受不受管制的补充剂. 然而,缺乏政策和培训等障碍阻碍了采用,需要这个新兴利基的合作解决方案.
科学领域:
- 运动药房 运动药房
- 社区药房实践 社区药房实践
- 医疗保健专业人员的角色
背景情况:
- 药剂师在运动员的安全和福祉中发挥着至关重要的作用.
- 体育药房是社区药房的一个新兴和未经探索的领域.
- 了解社区药剂师的观点对于服务发展至关重要.
研究的目的:
- 探索社区药剂师对马来西亚体育药房服务的看法.
- 确定影响社区药剂师采用体育药房服务的因素.
主要方法:
- 与社区药剂师进行了半结构化的在线访谈.
- 采访发生在2024年2月至8月之间.
- 数据分析采用了框架方法,将主题映射到综合行为模型中.
主要成果:
- 药剂师表达了保护运动员,特别是业余运动员免受不受监管的补充剂的道德义务.
- 重要的障碍包括缺乏标准化政策,薪酬和私人咨询基础设施.
- 提供服务的意图取决于先前的反兴奋剂教育和感知到的商业机会.
结论:
- 社区药剂师需要加强体育相关服务的知识和培训.
- 政府,药品机构和反兴奋剂机构之间的合作是必要的,以克服障碍.
- 这些发现可以指导体育药房作为一个有价值的社区药房利基的未来发展.
相关概念视频
Primary Healthcare Services
2.6K
Primary care promotes wellness and prevents disease. This care includes health promotion, education, protection (such as immunizations), early disease screening, and environmental considerations. Settings providing this type of healthcare include physician offices, public health clinics, school nursing, and community health nursing.
In 1978, international leaders convened in Alma-Ata, Kazakhstan, for what would be a pivotal event in global health. The Alma-Ata Declaration was the first to call...
In 1978, international leaders convened in Alma-Ata, Kazakhstan, for what would be a pivotal event in global health. The Alma-Ata Declaration was the first to call...
2.6K
Pharmacokinetics in Geriatric Patients: Effect of Age on Drug Distribution
318
Drug distribution in the human body is influenced by several factors, including plasma protein concentration, body composition, blood flow, tissue-protein concentration, and tissue fluid pH. Among these, changes in plasma protein concentration and body composition due to aging significantly affect how drugs are distributed within the body. Specifically, aging is associated with a decrease in albumin levels by about 10% and an increase in α1-acid glycoprotein levels. These alterations are...
318
Model Approaches for Pharmacokinetic Data: Physiological Models
331
Physiological models in pharmacokinetics are instrumental in understanding the distribution and elimination of drugs within the body. These models describe the drug concentration within target organs, influenced by factors such as drug uptake, tissue volume, and blood flow. Drug uptake is governed by the partition coefficient, which signifies the drug concentration ratio in tissue to that in the blood. The blood flow rate to a specific tissue is expressed as Qt, and the rate of change in tissue...
331
Pharmaceutical Poisoning: Potential Scenarios
54
Pharmaceutical poisoning can occur through various channels, impacting an estimated 2 million hospitalized patients in the U.S. annually with serious adverse drug responses. These scenarios encompass both therapeutic uses, such as drug toxicity, where even standard dosages can lead to severe central nervous system depression, and non-therapeutic exposures, including accidental ingestion by children, and environmental and occupational exposures.Unintentional poisonings often involve exploratory...
54
Model Approaches for Pharmacokinetic Data: Distributed Parameter Models
309
Pharmacokinetic models are mathematical constructs that represent and predict the time course of drug concentrations in the body, providing meaningful pharmacokinetic parameters. These models are categorized into compartment, physiological, and distributed parameter models.
The distributed parameter models are specifically designed to account for variations and differences in some drug classes. This model is particularly useful for assessing regional concentrations of anticancer or...
The distributed parameter models are specifically designed to account for variations and differences in some drug classes. This model is particularly useful for assessing regional concentrations of anticancer or...
309
Analysis of Population Pharmacokinetic Data
897
Analysis of population pharmacokinetic data involves studying the behavior of drugs within diverse populations to understand their pharmacokinetic parameters. Traditional pharmacokinetic methods typically involve collecting samples from a few individuals and estimating these parameters. While these methods are commonly used, they have limitations in capturing the variability in drug response among individuals or heterogeneous populations. Population pharmacokinetics is employed to address these...
897


